In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

M8 Pharmaceuticals

http://www.moksha8.com/

Latest From M8 Pharmaceuticals

Deals Shaping The Medical Industry, June 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2016.

BioPharmaceutical Medical Device

AstraZeneca’s Ajay Gautam On Innovation From Emerging Markets: An Interview With PharmAsia News (Part 2 of 2)

AstraZeneca Head of Emerging Market Collaborations Ajay Gautam talks to PharmAsia News about the company’s R&D strategy and deals with local partners.

BioPharmaceutical China

AstraZeneca’s Ajay Gautam On Innovation From Emerging Markets: An Interview With PharmAsia News (Part 1 of 2)

AstraZeneca Head of Emerging Market Collaborations Ajay Gautam talks to PharmAsia News about the company’s R&D strategy and deals with local partners.

BioPharmaceutical China

Biopharma Dealmaking Quarterly Statistics, Q4 2012

At $4.2 billion, biopharma financing in Q4 2012 showed a 36% increase over Q3 with FOPOs again dominating as the most popular deal type. With 34 finalized biopharma M&As, Q4 was the most active quarter of all 2012 for acquisitions. The 108 biopharma alliances completed had a combined potential deal value of almost $2 billion; Johnson & Johnson, with seven tie-ups, was the busiest pharmaco during Q4.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • moksha8 Pharmaceuticals, Inc.
UsernamePublicRestriction

Register